| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Monopar Therapeutics (MNPR) has 11 insiders with recent SEC Form 4 filings, including 7 buys and 7 sells. MNPR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 567.6K | $36.08M | - | |
| CEO | 272.0K | $17.29M | - | |
| CEO | 85.7K | $5.45M | - | |
| COO | 48.3K | $3.07M | - | |
| Dir | 9.2K | $586.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Vu Quan Anh | Chief Financial Officer | Buy | 1,500 | $69.95 | $104,925.00 | New | -20.7% | - | |
| Dec 18, 2025 | Klausner Arthur J | Director | Sell | 5,121 | $67.15 | $343,889.09 | -22.2% | -11.7% | - | |
| Sep 24, 2025 | Tactic Pharma LLC | Chief Executive Officer | Sell | 550,229 | $63.61 | $34,999,956.64 | -66.9% | -3.5% | - | |
| Jul 14, 2025 | Robinson Chandler | Chief Executive Officer | Sell | 16,800 | $40.00 | $672,020.16 | -18.6% | +133.4% | - | |
| Jul 14, 2025 | Tsuchimoto Kim R | Director | Sell | 8,904 | $40.00 | $356,170.68 | -43.7% | +133.4% | - | |
| Jul 14, 2025 | Starr Christopher M | Director | Sell | 16,800 | $40.00 | $672,020.16 | -76.5% | +133.4% | - | |
| Apr 2, 2025 | Tactic Pharma LLC | Chief Executive Officer | Sell | 33,334 | $35.00 | $1,166,690.00 | -3.9% | -12.9% | +43.1% | |
| Oct 28, 2024 | Radhakrishnan Karthik | Chief Financial Officer | Buy | 1,550 | $16.25 | $25,187.50 | New | +88.0% | +348.2% | |
| Jun 20, 2024 | Cittadine Andrew69 | Chief Operating Officer | Buy | 32,508 | $0.79 | $25,573.85 | +10.2% | +17.1% | +876.5% | |
| Jun 17, 2024 | Cittadine Andrew69 | Chief Operating Officer | Buy | 36,000 | $0.91 | $32,894.40 | +9.3% | -2.6% | +693.0% |